Back to Search
JEFFREY FINE, MD
MD
Physical Medicine & Rehabilitation Physician
NPI: 1902837354IndividualAccepts Medicare
Specialties, Licenses & Credentials
Physical Medicine & Rehabilitation PhysicianPrimary
Physical Medicine & Rehabilitation
Code: 208100000X
206958(NY)
CMS Specialties
PrimaryPHYSICAL MEDICINE AND REHABILITATION
Education
NEW YORK MEDICAL COLLEGE
Class of 1993
Research & Publications (20)
A global sensitivity test for evaluating statistical hypotheses with nonidentifiable models.
PMID 19645705·Biometrics·2010
8-other
Expression of chemokine receptor CXCR3 by lymphocytes and plasmacytoid dendritic cells in human psoriatic lesions.
PMID 19517126·Arch Dermatol Res·2010
8-other
Uncovering symptom progression history from disease registry data with application to young cystic fibrosis patients.
PMID 19522871·Biometrics·2010
8-other
Comparison of standard hip MR arthrographic imaging planes and sequences for detection of arthroscopically proven labral tear.
PMID 19380568·AJR Am J Roentgenol·2009
4-observational
Improved vision-related function after ranibizumab vs photodynamic therapy: a randomized clinical trial.
PMID 19139332·Arch Ophthalmol·2009
3-trial
Nonparametric association analysis of exchangeable clustered competing risks data.
PMID 18549422·Biometrics·2009
8-other
Diaminocyclobutenediones as potent and orally bioavailable CXCR2 receptor antagonists: SAR in the phenolic amide region.
PMID 19525110·Bioorg Med Chem Lett·2009
7-preclinical
Characterization of a murine keyhole limpet hemocyanin (KLH)-delayed-type hypersensitivity (DTH) model: role for p38 kinase.
PMID 19616132·Int Immunopharmacol·2009
7-preclinical
3,4-Diamino-1,2,5-thiadiazole as potent and selective CXCR2 antagonists.
PMID 19200721·Bioorg Med Chem Lett·2009
4-observational
Fluoroalkyl alpha side chain containing 3,4-diamino-cyclobutenediones as potent and orally bioavailable CXCR2-CXCR1 dual antagonists.
PMID 19196511·Bioorg Med Chem Lett·2009
4-observational
Sample size for positive and negative predictive value in diagnostic research using case-control designs.
PMID 18556677·Biostatistics·2009
8-other
Nmur1-/- mice are not protected from cutaneous inflammation.
PMID 19070594·Biochem Biophys Res Commun·2009
7-preclinical
Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986-2006.
PMID 19026465·J Am Acad Dermatol·2009
8-other
Accuracy of dynamic computed tomography to calculate rotation occurring at lumbar spinal motion segments.
PMID 19282727·Spine (Phila Pa 1976)·2009
4-observational
Gender differences in BOLD activation to face photographs and video vignettes.
PMID 19428627·Behav Brain Res·2009
8-other
A velocity driven lumped-parameter model of mitral valve blood flow - biomed 2009.
PMID 19369796·Biomed Sci Instrum·2009
8-other
Background fluctuation of kidney function versus contrast-induced nephrotoxicity.
PMID 19234268·AJR Am J Roentgenol·2009
4-observational
Outcomes following active surveillance of men with localized prostate cancer diagnosed in the prostate specific antigen era.
PMID 18707696·J Urol·2008
4-observational
The risk of cardiomyopathy in inherited epidermolysis bullosa.
PMID 18616785·Br J Dermatol·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 150 55TH ST FL 1
BROOKLYN, NY 11220 - Phone
- (718) 630-8600
Quick Facts
- NPI
- 1902837354
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 33
- Publications
- 20
Are you this provider?
Claim Your Profile